Lexeo Therapeutics to report third-quarter financial results

LXEO•2026-11-15

Lexeo Therapeutics will report third-quarter 2026 financial results and provide a business update on Nov. 16, 2026, with a webcast beginning at 8 a.m. ET.

1. Results and webcast

Lexeo Therapeutics will report third-quarter 2026 financial results on Nov. 16, 2026. Its business update will cover the HEROIC-PKP2 Phase I/II trial of LX2020 for PKP2 arrhythmogenic cardiomyopathy; a webcast will begin at 8 a.m. ET.

Lexeo Therapeutics to report third-quarter financial results

1. Results and webcast

Related News

Trump's minerals push has yet to loosen China's grip ahead of Xi talks

Tesla invites select customers to buy Cybercab for personal use

Nasdaq trade halt continues, news pending at 3:28 a.m.

‘I don’t know what to do’: student pilot on first solo flight caught in US shutdown

Vivani Medical Chief Business Officer Donald Dwyer reports acquisition of $19,645 in common shares